{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:31:27Z","timestamp":1791469887852,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Robotic waterjet ablation (RWJA), known by the trade name of Aquablation, is a minimally invasive, heat-free technique for treating benign prostatic hyperplasia (BPH) that offers comparable efficacy to transurethral resection of the prostate (TURP). Unlike TURP, RWJA utilizes targeted tissue mapping, potentially enhancing the preservation of sexual function, particularly antegrade ejaculation. This systematic review evaluated sexual outcomes following RWJA, emphasizing ejaculatory dysfunction and antegrade ejaculation preservation. A literature search conducted through January 1, 2025, in PubMed, Embase, and Cochrane databases identified 15 studies involving 1533 patients. Preservation rates of antegrade ejaculation post-RWJA ranged from 72 to 99.6%. Erectile function remained stable across all reviewed studies. Notably, a randomized controlled trial comparing RWJA to TURP demonstrated significantly lower rates of ejaculatory dysfunction in the RWJA group, maintained for up to five years. Despite promising findings indicating durable preservation of ejaculatory function, there remain limitations due to a scarcity of randomized controlled trials and limited long-term follow-up beyond 12 months. Future comparative studies evaluating RWJA against other minimally invasive BPH treatments are needed to further validate these findings and better define the sexual function outcomes associated with this innovative procedure.<\/jats:p>","DOI":"10.1038\/s41443-025-01087-6","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:35:40Z","timestamp":1747222540000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ejaculatory function after robotic waterjet ablation for the treatment of benign prostatic hyperplasia: a systematic review"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3256-7721","authenticated-orcid":false,"given":"Anthony","family":"Bettencourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1177-8039","authenticated-orcid":false,"given":"Joseph A.","family":"Borrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago P.","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7833-7071","authenticated-orcid":false,"given":"Jesse N.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-8905","authenticated-orcid":false,"given":"Rajiv","family":"Jayadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-4833","authenticated-orcid":false,"given":"Sriram V.","family":"Eleswarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"1087_CR1","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","volume":"173","author":"JT Wei","year":"2005","unstructured":"Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173:1256\u201361.","journal-title":"J Urol"},{"key":"1087_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0090-4295(01)01673-9","volume":"59","author":"EA Platz","year":"2002","unstructured":"Platz EA, Smit E, Curhan GC, Nyberg LM, Giovannucci E. Prevalence of and racial\/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology. 2002;59:877\u201383.","journal-title":"Urology"},{"key":"1087_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00345-024-05439-7","volume":"43","author":"JG Porto","year":"2025","unstructured":"Porto JG, Bhatia AM, Bhat A, Suarez Arbelaez MC, Blachman-Braun R, Shah K, et al. Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century. World J Urol. 2025;43:85.","journal-title":"World J Urol"},{"key":"1087_CR4","first-page":"22","volume":"23","author":"G Marra","year":"2016","unstructured":"Marra G, Sturch P, Oderda M, Tabatabaei S, Muir G, Gontero P. Systematic review of lower urinary tract symptoms\/benign prostatic hyperplasia surgical treatments on men\u2019s ejaculatory function: time for a bespoke approach? Int J Urol Off J Jpn Urol Assoc. 2016;23:22\u201335.","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"key":"1087_CR5","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jsxm.2020.07.006","volume":"17","author":"D Bouhadana","year":"2020","unstructured":"Bouhadana D, Nguyen DD, Zorn KC, Elterman DS, Bhojani N. Patient perspectives on benign prostatic hyperplasia surgery: a focus on sexual health. J Sex Med. 2020;17:2108\u201312.","journal-title":"J Sex Med"},{"key":"1087_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/bju.13358","volume":"117","author":"P Gilling","year":"2016","unstructured":"Gilling P, Reuther R, Kahokehr A, Fraundorfer M. Aquablation - Image-guided robot-assisted waterjet ablation of the prostate: Initial clinical experience. BJU Int. 2016;117:923\u20139.","journal-title":"BJU Int"},{"key":"1087_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of lower urinary tract symptoms attributed to Benign Prostatic Hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211:11\u20139.","journal-title":"J Urol"},{"key":"1087_CR8","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24:8802\u201313.","journal-title":"Can J Urol"},{"key":"1087_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021;206:715\u201324.","journal-title":"J Urol"},{"key":"1087_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-020-01012-y","volume":"21","author":"SD Lokeshwar","year":"2020","unstructured":"Lokeshwar SD, Valancy D, Lima TFN, Blachman-Braun R, Ramasamy R. A systematic review of reported ejaculatory dysfunction in clinical trials evaluating minimally invasive treatment modalities for BPH. Curr Urol Rep. 2020;21:54.","journal-title":"Curr Urol Rep"},{"key":"1087_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41443-019-0158-3","volume":"31","author":"G Reale","year":"2019","unstructured":"Reale G, Cimino S, Bruno G, Palmieri F, Giardina R, Russo GI, et al. \u201cAquabeam\u00ae System\u201d for benign prostatic hyperplasia and LUTS: birth of a new era. A systematic review of functional and sexual outcome and adverse events of the technique. Int J Impot Res. 2019;31:392\u20139.","journal-title":"Int J Impot Res"},{"key":"1087_CR12","first-page":"10960","volume":"29","author":"PJ Gilling","year":"2022","unstructured":"Gilling PJ, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol. 2022;29:10960\u20138.","journal-title":"Can J Urol"},{"key":"1087_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.","journal-title":"Syst Rev"},{"key":"1087_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1087_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.urology.2004.04.056","volume":"64","author":"RC Rosen","year":"2004","unstructured":"Rosen RC, Catania J, Pollack L, Althof S, O\u2019Leary M, Seftel AD. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. Urology. 2004;64:777\u201382.","journal-title":"Urology"},{"key":"1087_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.urology.2007.02.036","volume":"69","author":"RC Rosen","year":"2007","unstructured":"Rosen RC, Catania JA, Althof SE, Pollack LM, O\u2019Leary M, Seftel AD, et al. Development and validation of four-item version of male sexual health questionnaire to assess ejaculatory dysfunction. Urology. 2007;69:805\u20139.","journal-title":"Urology"},{"key":"1087_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822\u201330.","journal-title":"Urology"},{"key":"1087_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg"},{"key":"1087_CR19","first-page":"9317","volume":"25","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Hussain M. Aquablation versus transurethral resection of the prostate: 1 year United States - cohort outcomes. Can J Urol. 2018;25:9317\u201322.","journal-title":"Can J Urol"},{"key":"1087_CR20","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.5489\/cuaj.5730","volume":"12","author":"D Nguyen","year":"2018","unstructured":"Nguyen D, Zorn KC, Elterman D, Paterson R, So A, Goldenberg L, et al. Aquablation of the prostate: canadian experience. Can Urol Assoc J. 2018;12:S200.","journal-title":"Can Urol Assoc J"},{"key":"1087_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41443-018-0045-3","volume":"30","author":"FA Yafi","year":"2018","unstructured":"Yafi FA, Tallman CT, Seard ML, Jordan ML. Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80\u2013150 cc). Int J Impot Res. 2018;30:209\u201314.","journal-title":"Int J Impot Res"},{"key":"1087_CR22","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1007\/s00345-020-03534-z","volume":"39","author":"D Whiting","year":"2021","unstructured":"Whiting D, Ng KL, Barber N. Initial single centre experience of Aquablation of the prostate using the AquaBeam system with athermal haemostasis for the treatment of benign prostatic hyperplasia: 1-year outcomes. World J Urol. 2021;39:3019\u201324.","journal-title":"World J Urol"},{"key":"1087_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.urology.2021.01.023","volume":"153","author":"DD Nguyen","year":"2021","unstructured":"Nguyen DD, Mantri SS, Zorn KC, Misra\u00ef V, Elterman D, Bhojani N. Which anatomic structures should be preserved during aquablation contour planning to optimize ejaculatory function? A case-control study using ultrasound video recordings to identify surgical predictors of postoperative anejaculation. Urology. 2021;153:250\u20135.","journal-title":"Urology"},{"key":"1087_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/bju.14426","volume":"123","author":"M Plante","year":"2019","unstructured":"Plante M, Gilling P, Barber N, Bidair M, Anderson P, Sutton M, et al. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial. BJU Int. 2019;123:651\u201360.","journal-title":"BJU Int"},{"key":"1087_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/bju.14917","volume":"125","author":"DD Nguyen","year":"2020","unstructured":"Nguyen DD, Barber N, Bidair M, Gilling P, Anderson P, Zorn KC, et al. Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30\u201380 and 80\u2013150 mL prostates. BJU Int. 2020;125:112\u201322.","journal-title":"BJU Int"},{"key":"1087_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"P Gilling","year":"2018","unstructured":"Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. WATER: a double-blind, randomized, controlled trial of Aquablation\u00ae vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol. 2018;199:1252\u201361.","journal-title":"J Urol"},{"key":"1087_CR27","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s12325-019-00952-3","volume":"36","author":"P Gilling","year":"2019","unstructured":"Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Two-year outcomes after aquablation compared to TURP: efficacy and ejaculatory improvements sustained. Adv Ther. 2019;36:1326\u201336.","journal-title":"Adv Ther"},{"key":"1087_CR28","first-page":"10072","volume":"27","author":"P Gilling","year":"2020","unstructured":"Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial. Can J Urol. 2020;27:10072\u20139.","journal-title":"Can J Urol"},{"key":"1087_CR29","first-page":"11650","volume":"30","author":"K Oumedjbeur","year":"2023","unstructured":"Oumedjbeur K, Corsi NJ, Bouhadana D, Ibrahim A, Nguyen DD, Matta I, et al. Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50\u201380 mL. Can J Urol. 2023;30:11650\u20138.","journal-title":"Can J Urol"},{"key":"1087_CR30","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s00345-022-04137-6","volume":"40","author":"BL Raizenne","year":"2022","unstructured":"Raizenne BL, Bouhadana D, Zorn KC, Barber N, Gilling P, Kaplan S, et al. Functional and surgical outcomes of Aquablation in elderly men. World J Urol. 2022;40:2515\u201320.","journal-title":"World J Urol"},{"key":"1087_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2019.04.029","volume":"129","author":"N Bhojani","year":"2019","unstructured":"Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, et al. Aquablation for benign prostatic hyperplasia in large prostates (80\u2013150 cc): 1-year results. Urology. 2019;129:1\u20137.","journal-title":"Urology"},{"key":"1087_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.eururo.2019.06.024","volume":"76","author":"V Misrai","year":"2019","unstructured":"Misrai V, Rijo E, Zorn KC, Barry-Delongchamps N, Descazeaud A. Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first french aquablation clinical registry. Eur Urol. 2019;76:667\u201375.","journal-title":"Eur Urol"},{"key":"1087_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/jcm9020603","volume":"9","author":"T Bach","year":"2020","unstructured":"Bach T, Gilling P, El Hajj A, Anderson P, Barber N. First multi-center all-comers study for the aquablation procedure. J Clin Med. 2020;9:603.","journal-title":"J Clin Med"},{"key":"1087_CR34","first-page":"222","volume":"74","author":"D D\u2019agostino","year":"2021","unstructured":"D\u2019agostino D, Colicchia M, Corsi P, Romagnoli D, Del Rosso A, Modonutti D, et al. The combination of waterjet ablation (Aquabeam\u00ae) and holmium laser power for treatment of symptomatic benign prostatic hyperplasia: early functional results. Cent Eur J Urol. 2021;74:222\u20138.","journal-title":"Cent Eur J Urol"},{"key":"1087_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00345-021-03898-w","volume":"40","author":"A El Hajj","year":"2022","unstructured":"El Hajj A, Misrai V, Nasrallah AA, Labban ML, Najdi JA, Rijo E. Learning curve in aquablation: an international multicenter study. World J Urol. 2022;40:773\u20139.","journal-title":"World J Urol"},{"key":"1087_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00345-024-04997-0","volume":"42","author":"J Michaelis","year":"2024","unstructured":"Michaelis J, Tr\u00e4ger M, Astheimer S, von B\u00fcren M, Gabele E, Grabbert M, et al. Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized study. World J Urol. 2024;42:306.","journal-title":"World J Urol"},{"key":"1087_CR37","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00345-018-2509-y","volume":"37","author":"T Bach","year":"2019","unstructured":"Bach T, Giannakis I, Bachmann A, Fiori C, Gomez-Sancha F, Herrmann TRW, et al. Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort. World J Urol. 2019;37:1369\u201375.","journal-title":"World J Urol"},{"key":"1087_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4111\/icu.20200249","volume":"62","author":"M Labban","year":"2021","unstructured":"Labban M, Mansour M, Abdallah N, Jaafar R, Wazzan W, Bulbul M, et al. Aquablation for benign prostatic obstruction: single center technique evolution and experience. Investig Clin Urol. 2021;62:210\u20136.","journal-title":"Investig Clin Urol"},{"key":"1087_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00345-024-05380-9","volume":"43","author":"D Amparore","year":"2024","unstructured":"Amparore D, De Cillis S, Quara A, Sica M, Ortenzi M, Piramide F, et al. Assessing Micturition, sexual function, and endoscopic outcomes one year after Aquablation: a single center prospective study. World J Urol. 2024;43:20.","journal-title":"World J Urol"},{"key":"1087_CR40","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.juro.2017.01.056","volume":"197","author":"P Gilling","year":"2017","unstructured":"Gilling P, Anderson P, Tan A. Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol. 2017;197:1565\u201372.","journal-title":"J Urol"},{"key":"1087_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.urology.2024.07.047","volume":"194","author":"OO Omidele","year":"2024","unstructured":"Omidele OO, Siegal AS, Roshandel R, Te AE, Kaplan SA. Aquablation at 4-years: real world data from the largest single-center study with associated outcomes follow-up. Urology. 2024;194:216\u201320.","journal-title":"Urology"},{"key":"1087_CR42","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s11255-022-03244-y","volume":"54","author":"CH Yee","year":"2022","unstructured":"Yee CH, Tang SF, Yuen SKK, Chan CK, Teoh JYC, Chiu PKF, et al. Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation. Int Urol Nephrol. 2022;54:1787\u201392.","journal-title":"Int Urol Nephrol"},{"key":"1087_CR43","first-page":"308","volume":"32","author":"N Hinata","year":"2025","unstructured":"Hinata N, Fujisawa M, Yamaguchi R, Katsura D, Kitano H, Sekino Y, et al. AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population. Int J Urol Off J Jpn Urol Assoc. 2025;32:308\u201313.","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"key":"1087_CR44","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American urological association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549\u201357.","journal-title":"J Urol"},{"key":"1087_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.urology.2022.07.007","volume":"169","author":"T Bach","year":"2022","unstructured":"Bach T, Barber N, Elterman D, Humphreys M, Bhojani N, Zorn KC, et al. Aquablation outcomes in men with LUTS due to BPH following single versus multi-pass treatments. Urology. 2022;169:167\u201372.","journal-title":"Urology"},{"key":"1087_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2164\/jandrol.106.000372","volume":"28","author":"F Meng","year":"2007","unstructured":"Meng F, Gao B, Fu Q, Chen J, Liu Y, Shi B, et al. Change of sexual function in patients before and after ho:YAG laser enucleation of the prostate. J Androl. 2007;28:259\u201361.","journal-title":"J Androl"},{"key":"1087_CR47","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0022-5347(05)00983-3","volume":"175","author":"A Briganti","year":"2006","unstructured":"Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-Center, randomized trial. J Urol. 2006;175:1817\u201321.","journal-title":"J Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01087-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01087-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01087-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:03:59Z","timestamp":1770807839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01087-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1087"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01087-6","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jesse N. Mills is a consultant for Halozyme Pharma, Boston Scientific, and Endo Pharmaceuticals. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This manuscript reviews the current literature regarding sexual outcomes after Aquablation, and thus, no IRB approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}